PHARMANUTRA SPA (PHN.MI) Stock Fundamental Analysis
Europe - BIT:PHN - IT0005274094 - Common Stock
45.9 EUR
+0.1 (+0.22%)
Taking everything into account, PHN scores 7 out of 10 in our fundamental rating. PHN was compared to 13 industry peers in the Personal Care Products industry. PHN gets an excellent profitability rating and is at the same time showing great financial health properties. PHN is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings could make PHN a good candidate for growth and quality investing.
1. Profitability
1.1 Basic Checks
PHN had positive earnings in the past year.
PHN had a positive operating cash flow in the past year.
PHN had positive earnings in each of the past 5 years.
Each year in the past 5 years PHN had a positive operating cash flow.
1.2 Ratios
PHN has a Return On Assets of 20.41%. This is amongst the best in the industry. PHN outperforms 100.00% of its industry peers.
PHN's Return On Equity of 38.54% is amongst the best of the industry. PHN outperforms 100.00% of its industry peers.
PHN has a Return On Invested Capital of 26.24%. This is amongst the best in the industry. PHN outperforms 100.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for PHN is above the industry average of 12.37%.
The last Return On Invested Capital (26.24%) for PHN is above the 3 year average (17.21%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 20.41% | ||
| ROE | 38.54% | ||
| ROIC | 26.24% |
ROA(3y)13.53%
ROA(5y)17.42%
ROE(3y)26.61%
ROE(5y)29.54%
ROIC(3y)17.21%
ROIC(5y)18.21%
1.3 Margins
PHN has a Profit Margin of 13.48%. This is in the better half of the industry: PHN outperforms 76.92% of its industry peers.
PHN's Profit Margin has declined in the last couple of years.
PHN has a better Operating Margin (21.87%) than 100.00% of its industry peers.
In the last couple of years the Operating Margin of PHN has remained more or less at the same level.
With an excellent Gross Margin value of 97.04%, PHN belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
PHN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.87% | ||
| PM (TTM) | 13.48% | ||
| GM | 97.04% |
OM growth 3Y-4.84%
OM growth 5Y1.01%
PM growth 3Y-10.74%
PM growth 5Y-1.82%
GM growth 3Y-0.75%
GM growth 5Y-0.04%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), PHN is creating value.
Compared to 1 year ago, PHN has about the same amount of shares outstanding.
PHN has less shares outstanding than it did 5 years ago.
The debt/assets ratio for PHN has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 8.63 indicates that PHN is not in any danger for bankruptcy at the moment.
The Altman-Z score of PHN (8.63) is better than 100.00% of its industry peers.
The Debt to FCF ratio of PHN is 2.70, which is a good value as it means it would take PHN, 2.70 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.70, PHN is in the better half of the industry, outperforming 69.23% of the companies in the same industry.
A Debt/Equity ratio of 0.28 indicates that PHN is not too dependend on debt financing.
PHN has a Debt to Equity ratio of 0.28. This is in the better half of the industry: PHN outperforms 61.54% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.28 | ||
| Debt/FCF | 2.7 | ||
| Altman-Z | 8.63 |
ROIC/WACC3.32
WACC7.9%
2.3 Liquidity
A Current Ratio of 2.06 indicates that PHN has no problem at all paying its short term obligations.
PHN has a better Current ratio (2.06) than 92.31% of its industry peers.
A Quick Ratio of 1.75 indicates that PHN should not have too much problems paying its short term obligations.
PHN has a Quick ratio of 1.75. This is amongst the best in the industry. PHN outperforms 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.06 | ||
| Quick Ratio | 1.75 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 20.20% over the past year.
Measured over the past years, PHN shows a quite strong growth in Earnings Per Share. The EPS has been growing by 14.63% on average per year.
Looking at the last year, PHN shows a quite strong growth in Revenue. The Revenue has grown by 15.06% in the last year.
PHN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.59% yearly.
EPS 1Y (TTM)20.2%
EPS 3Y6.71%
EPS 5Y14.63%
EPS Q2Q%3.36%
Revenue 1Y (TTM)15.06%
Revenue growth 3Y19.25%
Revenue growth 5Y16.59%
Sales Q2Q%10.35%
3.2 Future
PHN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.52% yearly.
The Revenue is expected to grow by 12.05% on average over the next years. This is quite good.
EPS Next Y8.85%
EPS Next 2Y12.93%
EPS Next 3Y13.52%
EPS Next 5YN/A
Revenue Next Year14.06%
Revenue Next 2Y14.01%
Revenue Next 3Y13.43%
Revenue Next 5Y12.05%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 18.73, PHN is valued on the expensive side.
Compared to the rest of the industry, the Price/Earnings ratio of PHN indicates a rather cheap valuation: PHN is cheaper than 84.62% of the companies listed in the same industry.
PHN's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.51.
Based on the Price/Forward Earnings ratio of 18.92, the valuation of PHN can be described as rather expensive.
PHN's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of PHN to the average of the S&P500 Index (22.53), we can say PHN is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.73 | ||
| Fwd PE | 18.92 |
4.2 Price Multiples
61.54% of the companies in the same industry are more expensive than PHN, based on the Enterprise Value to EBITDA ratio.
76.92% of the companies in the same industry are cheaper than PHN, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 54.24 | ||
| EV/EBITDA | 10.41 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PHN does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of PHN may justify a higher PE ratio.
PHN's earnings are expected to grow with 13.52% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.12
PEG (5Y)1.28
EPS Next 2Y12.93%
EPS Next 3Y13.52%
5. Dividend
5.1 Amount
PHN has a Yearly Dividend Yield of 2.16%.
Compared to an average industry Dividend Yield of 2.54, PHN pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.38, PHN has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.16% |
5.2 History
The dividend of PHN is nicely growing with an annual growth rate of 11.21%!
Dividend Growth(5Y)11.21%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
PHN pays out 40.63% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of PHN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP40.63%
EPS Next 2Y12.93%
EPS Next 3Y13.52%
BIT:PHN (11/4/2025, 5:29:56 PM)
45.9
+0.1 (+0.22%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners17.08%
Inst Owner ChangeN/A
Ins Owners65.02%
Ins Owner ChangeN/A
Market Cap444.31M
Revenue(TTM)175.08M
Net Income(TTM)23.61M
Analysts83.33
Price Target82.62 (80%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.16% |
Yearly Dividend0.85
Dividend Growth(5Y)11.21%
DP40.63%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.53%
PT rev (3m)-1.22%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-6.53%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.29%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.73 | ||
| Fwd PE | 18.92 | ||
| P/S | 2.54 | ||
| P/FCF | 54.24 | ||
| P/OCF | 36.05 | ||
| P/B | 7.25 | ||
| P/tB | 11.9 | ||
| EV/EBITDA | 10.41 |
EPS(TTM)2.45
EY5.34%
EPS(NY)2.43
Fwd EY5.29%
FCF(TTM)0.85
FCFY1.84%
OCF(TTM)1.27
OCFY2.77%
SpS18.09
BVpS6.33
TBVpS3.86
PEG (NY)2.12
PEG (5Y)1.28
Graham Number18.68
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 20.41% | ||
| ROE | 38.54% | ||
| ROCE | 45.24% | ||
| ROIC | 26.24% | ||
| ROICexc | 32.19% | ||
| ROICexgc | 49.25% | ||
| OM | 21.87% | ||
| PM (TTM) | 13.48% | ||
| GM | 97.04% | ||
| FCFM | 4.68% |
ROA(3y)13.53%
ROA(5y)17.42%
ROE(3y)26.61%
ROE(5y)29.54%
ROIC(3y)17.21%
ROIC(5y)18.21%
ROICexc(3y)25.61%
ROICexc(5y)33.67%
ROICexgc(3y)43.23%
ROICexgc(5y)50.61%
ROCE(3y)29.76%
ROCE(5y)31.61%
ROICexgc growth 3Y-15.98%
ROICexgc growth 5Y-10.26%
ROICexc growth 3Y-20.69%
ROICexc growth 5Y-11.75%
OM growth 3Y-4.84%
OM growth 5Y1.01%
PM growth 3Y-10.74%
PM growth 5Y-1.82%
GM growth 3Y-0.75%
GM growth 5Y-0.04%
F-Score7
Asset Turnover1.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.28 | ||
| Debt/FCF | 2.7 | ||
| Debt/EBITDA | 0.4 | ||
| Cap/Depr | 97.13% | ||
| Cap/Sales | 2.36% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 28.97% | ||
| Profit Quality | 34.7% | ||
| Current Ratio | 2.06 | ||
| Quick Ratio | 1.75 | ||
| Altman-Z | 8.63 |
F-Score7
WACC7.9%
ROIC/WACC3.32
Cap/Depr(3y)763.09%
Cap/Depr(5y)544.05%
Cap/Sales(3y)14.97%
Cap/Sales(5y)11.04%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.2%
EPS 3Y6.71%
EPS 5Y14.63%
EPS Q2Q%3.36%
EPS Next Y8.85%
EPS Next 2Y12.93%
EPS Next 3Y13.52%
EPS Next 5YN/A
Revenue 1Y (TTM)15.06%
Revenue growth 3Y19.25%
Revenue growth 5Y16.59%
Sales Q2Q%10.35%
Revenue Next Year14.06%
Revenue Next 2Y14.01%
Revenue Next 3Y13.43%
Revenue Next 5Y12.05%
EBIT growth 1Y14.83%
EBIT growth 3Y13.47%
EBIT growth 5Y17.77%
EBIT Next Year22.06%
EBIT Next 3Y16.37%
EBIT Next 5Y9.96%
FCF growth 1Y144.25%
FCF growth 3Y1.75%
FCF growth 5Y17.94%
OCF growth 1Y38.33%
OCF growth 3Y0.14%
OCF growth 5Y11.34%
PHARMANUTRA SPA / PHN.MI FAQ
What is the fundamental rating for PHN stock?
ChartMill assigns a fundamental rating of 7 / 10 to PHN.MI.
What is the valuation status for PHN stock?
ChartMill assigns a valuation rating of 4 / 10 to PHARMANUTRA SPA (PHN.MI). This can be considered as Fairly Valued.
How profitable is PHARMANUTRA SPA (PHN.MI) stock?
PHARMANUTRA SPA (PHN.MI) has a profitability rating of 8 / 10.
Can you provide the financial health for PHN stock?
The financial health rating of PHARMANUTRA SPA (PHN.MI) is 8 / 10.
How sustainable is the dividend of PHARMANUTRA SPA (PHN.MI) stock?
The dividend rating of PHARMANUTRA SPA (PHN.MI) is 6 / 10 and the dividend payout ratio is 40.63%.